tisseel fibrin sealant vh sd (frozen)
baxter healthcare (asia) pte ltd - aprotinin (synthetic) (for sealer protein solution); calcium chloride (for thrombin solution); fibrinogen (clottable protein) (for sealer protein solution); thrombin (for thrombin solution) - solution - aprotinin (synthetic) (for sealer protein solution) 2250-3750 kiu/ml; calcium chloride (for thrombin solution) 36-44 umol/ml; fibrinogen (clottable protein) (for sealer protein solution) 72-110 mg/ml; thrombin (for thrombin solution) 400-625 iu/ml
riastap- fibrinogen human injection, powder, lyophilized, for solution
csl behring gmbh - fibrinogen human (unii: n94833051k) (fibrinogen human - unii:n94833051k) - fibrinogen human 1300 mg in 50 ml - riastap® , fibrinogen concentrate (human) is a human blood coagulation factor indicated for the treatment of acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. limitation of use riastap is not indicated for dysfibrinogenemia. riastap is contraindicated in patients with known anaphylactic or severe systemic reactions to human plasma-derived products. risk summary there are no studies of riastap use in pregnant women. animal reproduction studies have not been conducted with riastap. it is not known whether riastap can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. risk summary there is no information regarding the presence of riastap in human milk, its effects on the breastfed infant, or its effects on mi
coopers bovilis rotavec corona calf scours vaccine
intervet australia pty limited - bovine rotavirus (ncdv); clostridium perfringens type c toxoid; escherichia coli k99 pilus antigens; clostridium perfringens type d toxoid; bovine coronavirus (inactivated) - misc. vaccines or anti sera - bovine rotavirus (ncdv) biological-virus active 1.0 rp; clostridium perfringens type c toxoid vaccine-toxoid active 10.0 iu/ml; escherichia coli k99 pilus antigens vaccine-microbial active 1.0 rp; clostridium perfringens type d toxoid vaccine-toxoid active 2.0 iu/ml; bovine coronavirus (inactivated) vaccine-viral active 1.0 rp - immunotherapy - cow | healthy pregnant heifer | bovine | female cattle - bovine rotaviruses | neonatal calf diarrhea | neonatal enterotoxemia | raise colostral antibodies | against bovine rotavirus and | coronavirus | enterotoxigenic e.coli pilus | g6 and g10 | type k99
pestigard vaccine
zoetis australia pty ltd - inactivated bovine pestivirus - bega strain; inactivated bovine pestivirus - trangie strain; thiomersal - misc. vaccines or anti sera - inactivated bovine pestivirus - bega strain vaccine-viral active 0.0 p; inactivated bovine pestivirus - trangie strain vaccine-viral active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bovine pestivirus
bovilis ibr marker live, lyophilisate and solvent for suspension for cattle
intervet ireland limited - glycoprotein e deficient (ge-) bovine herpes virus type 1 (bhv-1), strain gk/d (ge-)1 - lyophilisate and solvent for suspension for injection - . - bovine rhinotracheitis virus (ibr) - cattle - immunological - live vaccine
inforce 3 freeze-dried vaccine with sterile diluent for injection
bovine rhinotracheitis virus (ibr) (strain rlb 106), bovine parainfluenza 3 virus (pi3) (strain rlb103) and respiratory syncytial virus (brsv) (strain brsv/375) - freeze-dried vaccine with sterile diluent for injection - each dose contains: - (ibr) (strain rlb 106) ≥106.0tcid50 at release and ≥105.5tcid50 at expiration, - (pi3) (strain rlb103) ≥105.5tcid50 at release and ≥105.0tcid50 at expiration and - (brsv) (strain brsv/375) ≥105.2tcid50 at release
ultravac scourshield vaccine
zoetis australia pty ltd - bovine rotavirus g10; bovine rotavirus g6; e. coli strain - o64:k99; bovine coronavirus (inactivated); gentamicin; formaldehyde; thiomersal - misc. vaccines or anti sera - bovine rotavirus g10 active 1.0 rp/2ml d; bovine rotavirus g6 active 1.3 rp/2ml d; e. coli strain - o64:k99 vaccine-microbial active 1.0 rp/2ml d; bovine coronavirus (inactivated) vaccine-viral active 1.0 rp/2ml d; gentamicin antibiotic other 30.0 ug/ml; formaldehyde aldehyde other 0.74 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - cow - pregnant | healthy pregnant heifer | bovine | pregnant cow - neonatal calf diarrhea
artiss fibrinogen human thrombin
baxter healthcare corporation - fibrinogen human (unii: n94833051k) (fibrinogen human - unii:n94833051k) - fibrinogen human 90 mg in 1 ml
bovilis mh + ibr
schering-plough animal health limited - pasteurella haemolytica (inactivated); infectious bovine rhinotrocheitis virus (inactivated); pasteurella haemolytica (inactivated) - pasteurella haemolytica (inactivated) 0 vaccine; infectious bovine rhinotrocheitis virus (inactivated) 0 vaccine; pasteurella haemolytica (inactivated) 0 vaccine - vaccine
raplixa fibrinogen human and thrombin powder
profibrix bv - fibrinogen human (unii: n94833051k) (fibrinogen human - unii:n94833051k) - fibrinogen human 79 mg in 1 g